Happy New Year 2023!
AMRA’s Team is sending our best wishes of health, warmth and peace for this Holiday Season. In the coming year, we will…
Read MoreNews
AMRA Medical at AASLD 2022: Premier MRI Technology and Informatics for The Full Continuum of Liver Disease
AMRA Medical’s MRI-based technology and informatics are featured in seven abstracts accepted for presentation at The Liver Meeting 2022 – the world’s “must-attend” hepatology meeting.
Read More
AMRA Medical at EASD 2022 Conference: Two Abstracts Paving A New Path For Research With The Two Largest Diabetes Companies
AMRA Medical’s cutting-edge technology for body composition assessment was used in two separate studies for evaluating the effects of diabetes drugs—one being Lilly’s Tirzepatide, the other Novo Nordisk’s Liraglutide.
Read More
AMRA Medical Pivots — Both In Look and Focus
AMRA Medical launches a new brand identity and logo to align with its clinical focus.
Read More
Fulcrum Phase 3 FSHD Clinical Trial Using AMRA Medical’s Whole-body MRI Measurements as a Key Secondary Endpoint
REACH, a Phase 3 Clinical Trial of losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) utilizes AMRA’s Muscle Fat Infiltration (MFI) as a secondary…
Read More
AMRA Medical continues to advance FSHD research with whole-body MRI measurements
AMRA’s recent publication demonstrates the utility of MRI-based muscle composite scores in neuromuscular disease clinical trials. AMRA Medical, a digital health company…
Read More